An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-life
about
Widening and Elaboration of Consecutive Research into Therapeutic Antioxidant Enzyme DerivativesConjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its actionA novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathwayBiophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor.Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infectionBiochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor designDocetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanismAlbumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patientsA dicarboxylic fatty acid derivative of paclitaxel for albumin-assisted drug delivery.Peptide inhibitors against herpes simplex virus infections.Impact of physiochemical properties on pharmacokinetics of protein therapeutics.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.Peptide fusion inhibitors targeting the HIV-1 gp41: a patent review (2009 - 2014).Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.Evaluation of pharmacokinetic interactions between long-acting HIV-1 fusion inhibitor albuvirtide and lopinavir/ritonavir, in HIV-infected subjects, combined with clinical study and simulation results.Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy.HIV vs. HIV: Turning HIV-Derived Peptides into Drugs
P2860
Q26752431-4BE04042-50FD-4542-AD94-F8367D4B7CE2Q28485911-8B035F1C-569E-4E80-B696-7303EAE224CAQ34110775-08A024FB-0018-40E4-AD70-DD9B93F5E059Q34189558-715B4FE8-7009-4532-9465-7BCAEB396072Q34517381-AD415D00-FB44-4075-BE33-F2F7849ACA8FQ35160026-6CD8C6E8-B731-4EC7-91AC-2616CADECA8EQ35563298-D2F990F6-2A28-40CF-946A-4BF6AA931599Q35642480-FFB90D53-01F4-4905-9DB7-E848B91D32C3Q35942344-801652DD-E759-4E1D-A5D7-1BBBBB25CA52Q36565853-D08F79B3-1AC3-402F-B0B8-D7EDD6621F8FQ36742881-48F35463-D39A-4D3D-B2B8-84A8B30880E6Q38079780-9A898370-E234-414E-8D7E-8570C55F9C65Q38098934-17548285-5F85-4BEC-8771-AEA7FAB8C063Q38196457-1092EE2E-3910-46BE-ABE2-813A8612BC49Q38271873-71FDF1FF-D6E0-4F14-AB31-4ED4ABFFE377Q38699470-78FC605A-0727-4ED7-9300-FE70FB98E532Q40725569-89D2E0A5-20D8-4328-8D32-983DB7170BA2Q54237920-59C37FDD-D17D-4128-B72E-A4E1ECABF260Q58626543-6D754BCF-64CB-499E-AC88-E0CC01B90EC3
P2860
An albumin-conjugated peptide exhibits potent anti-HIV activity and long in vivo half-life
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
An albumin-conjugated peptide ...... ity and long in vivo half-life
@ast
An albumin-conjugated peptide ...... ity and long in vivo half-life
@en
An albumin-conjugated peptide ...... ty and long in vivo half-life.
@nl
type
label
An albumin-conjugated peptide ...... ity and long in vivo half-life
@ast
An albumin-conjugated peptide ...... ity and long in vivo half-life
@en
An albumin-conjugated peptide ...... ty and long in vivo half-life.
@nl
prefLabel
An albumin-conjugated peptide ...... ity and long in vivo half-life
@ast
An albumin-conjugated peptide ...... ity and long in vivo half-life
@en
An albumin-conjugated peptide ...... ty and long in vivo half-life.
@nl
P2093
P2860
P356
P1476
An albumin-conjugated peptide ...... ity and long in vivo half-life
@en
P2093
Jiahai Xiao
Jiahong Xu
Mingxian Huang
Wenjie Min
P2860
P304
P356
10.1128/AAC.00976-09
P407
P577
2009-10-26T00:00:00Z